Representation and outcomes for older patients in phase 3 clinical trials for metastatic and unresectable head and neck squamous cell carcinoma (HNSCC): A systematic review. This is an ASCO Meeting ...

Adjuvant Opdivo, cisplatin and radiotherapy improved DFS vs other treatment among those with locally advanced squamous cell ...

CHICAGO – The postoperative addition of nivolumab (Opdivo) to chemoradiotherapy (CRT) extended disease-free survival (DFS) in ...

Adding nivolumab to adjuvant CRT improved DFS in patients with locally advanced head and neck squamous cell carcinoma at high risk of relapse.

Immunotherapies are undoubtedly transforming the landscape of cancer treatment worldwide. By harnessing the body's immune ...

“Early diagnosis of oral cancer gives a person more than an 80% survival rate” While the incidence rates of oral cavity and pharynx ... cancers are oral squamous cell carcinoma, patients ...

About 40 percent of cancer cases are considered preventable. Try these lifestyle changes to stay healthy.

Get Instant Summarized Text (Gist) LSD1, an epigenetic regulator, is crucial in oral squamous cell carcinoma (OSCC) progression by modulating pathways such as STAT3 and CDK7. Inhibiting LSD1 ...

In the Phase 1/1b trial, ficerafusp alfa in combination with pembrolizumab resulted in deep and durable anti-tumor activity with improved overall survival (OS) compared to historical benchmarks in ...

Examining age-specific trends in the incidence of human papillomavirus-associated oropharyngeal cancer in the United States. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This ...